NCT05395949View on ClinicalTrials.gov

A Randomized Controlled Study of Conservative Treatment of Granulomatous Lobular Mastitis Combined With Psychiatric Disorders

NAEnrolling by invitationINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

December 30, 2022

Study Completion Date

January 30, 2027

Conditions
Breast DiseasesMastitis GranulomatousPsychiatric Disorder
Interventions
DRUG

conservative treatment

Prednisone 30 mg/day, supplemented with calcium and omeprazole, and Prednisone were slowly reduced to 10 mg/day after symptoms were relieved, and combined with 7.5 mg/week MTX therapy.

Trial Locations (1)

430071

Zhongnan Hospital of Wuhan University, Wuhan

All Listed Sponsors
lead

Wuhan University

OTHER